AccScience Publishing

Before you decide to publish with Advanced Neurology (AN), please read the following items carefully and make sure that you are well aware of Editorial Policies and the following requirements.

1.1 Topic Suitability

The topic of the manuscript must fit the scope of the journal. Please refer to Aims and Scope for more information.

1.2 Open Access and Copyright

The journal adopts the Gold Open Access publishing model and distributes content under the Creative Commons Attribution 4.0 International License. Copyright is retained by authors. Please make sure that you are well aware of these policies.

1.3 Publication Fees

The publication fee for each submission is USD 2200. There are no additional charges based on color, length, figures, or other elements. Refer to Article Processing Charges for our policy in waivers and discounts.

1.4 Language Editing

All submissions are required to be presented clearly and cohesively in good English. Authors whose first language is not English are advised to have their manuscripts checked or edited by a native English speaker before submission to ensure a high quality of expression. A well-organized manuscript in good English would make the peer review even the whole editorial handling more smoothly and efficiently.

1.5 The use of AI in manuscript preparation

Artificial intelligence (AI) and the products that come with it has seen a rising trajectory in recent years and the use of these products, mainly the software, in preparing manuscript is an area subject to dynamic changes that everyone—including publisher, editors, reviewers and authors—need to observe closely. At current stage, AccScience Publishing permits the use of AI-powered tools to polish and edit manuscripts submitted to our journals on the conditions that the changes made through the software are only confined to language polishing (including idiomacy, readability and coherence improvements) under human guidance. The core justification of this policy lies in our belief that findings, concepts, ideas and conclusions from a work, regardless of a research or a literature review, should be purely the outputs of human efforts, rather than summarizing power of AI; in short, AI is just a means to elevating your work for better readability and clarity, and should not be used to “generate new ideas and insights” and analyze data without human interventions or guidance. See section 2.3.1.13 (Further Disclosure) for the specific instructions on how to declare AI usage in submissions, and review section 7 (Policy of Use of AI and AI-assisted Technologies in Scientific Writing) for other limitations currently imposed on the use of AI or other AI-powered tools. Note that this editorial policy on AI usage is subject to change from time to time, aligning with how far the AI technology has evolved and the new regulations on AI application, by industrial standards, will be put in place in the future.

1.6 Work Funded by National Institutes of Health

If an accepted manuscript was funded by the National Institutes of Health (NIH), the authors may inform Editors of the NIH funding number. The Editors are able to upload the paper into the NIH Manuscript Submission System on behalf of the authors.

2. Submission Preparation

2.1 Cover Letter

A cover letter is required to be submitted accompanying each manuscript. It should be concise and explain why the work is significant, why it fits the scope of the journal, why it would be attractive to readers, and so on.

Here is a guideline of a cover letter for authors' consideration:
In the first paragraph: include the title and type (e.g., Original Research Article, Review, Case Report, etc.) of the manuscript, a brief on the background of the study, the question the author sought out to answer and why;
In the second paragraph: concisely explain what was done, the main findings and why they are significant;
In the third paragraph: indicate why the manuscript fits the Aims and Scope of the journal, and why it would be attractive to readers;
In the fourth paragraph: confirm that the manuscript has not been published elsewhere and has not been under consideration by any other journal. All authors have approved the manuscript and agreed on its submission to the journal. The journal's specific requirements have been met if any.
If the manuscript is contributed to a Special Issue, please also mention the Special Issue’s title in the cover letter.
If the findings and/or ideas of the submitted work have been presented partly or entirely at a conference/seminar/congress, the authors should clearly state the background information of the event, including the event name, time and place, in the cover letter.

2.2 Types of Manuscripts

The journal publishes Original Research Article, Review, Perspective Article, Case Report, Case Series, Letter, Editorial, etc. For more details about the article type, please refer to the following table.

Manuscript Type	Definition	Word Limit	Abstract	Keywords	Main Text Structure	References
Original Research Article	An Original Research Article describes detailed results from novel research. All findings should be extensively discussed.	No less than 5000	Unstructured abstract. No more than 250 words.	3-8 Keywords	The main text should include four sections: Introduction, Materials and methods, Results, Discussion, and Conclusion. The Results and Discussion sections can be merged, as appropriate.	Approximately 40 references
Review	A Review Article summarizes the literature on previous studies. It usually does not present any new information on a subject.	No less than 5000	Unstructured abstract. No more than 250 words.	3-8 Keywords	The main text may consist of several sections with unfixed section titles. We suggest that the author include an "Introduction" section at the beginning, several sections with unfixed titles in the middle part, and a "Conclusion" section in the end.	Approximately 70 references
Case Report	A Case Report details symptoms, signs, diagnosis and treatment in a unique case that is worth reporting, and chronicles the follow-up of an individual patient. The goal of a Case Report is to make other researchers aware of the possibility that a specific phenomenon might occur.	1500-2000	Unstructured abstract. No more than 250 words.	3-8 Keywords	The main text should contain four main sections: Background, Case presentation, Discussion, and Conclusion.	Approximately 15 references
Case Series	The Case Series section reports a series of 2-6 similar cases. The cases should address a challenging diagnostic and/or therapeutic problem with possible solutions to help clinicians in managing these cases. Case series must be accompanied with a comprehensive review of literature.	4000 max	Unstructured abstract. No more than 250 words.	3-8 Keywords	The main text should contain four main sections: Introduction, Case presentation, Discussion, and Conclusion.	No more than 30 references
Short Communication	A Short Communication is a short article that presents original and significant findings on a particular problem or novel findings that are anticipated to have significant impact.	4000 max	Unstructured abstract. No more than 250 words.	3-8 Keywords	The main text should include four sections: Introduction, Methods, Results, Discussion, and Conclusion. The Results and Discussion sections can be merged, as appropriate.	Approximately 15 references
Editorial	An Editorial is a short, opinionated piece, often contributed by the editors or the publisher, that discusses a relevant topic or issue within the journal's scope	1200 max	None required.	None required	/	Approximately 5 references
Letter to Editor	A Letter to Editor is usually an open post-publication review of a paper from its readers, often critical of some aspect of a published paper. Controversial papers often attract numerous Letters to Editor.	1500 max	None required.	3-8 Keywords (optional)	/	No more than 20 references
Perspective	A Perspective provides personal points of view on the frontiers of a specific area and its future prospects. Links to areas of intense current research focus can also be made. The emphasis should be on a personal assessment rather than a comprehensive, critical review. However, comments should be put into the context of existing literature. Perspectives are usually invited by the Editors.	2000-3000	Unstructured abstract. No more than 250 words.	3-8 Keywords	/	Approximately 10 references

2.3 Manuscript Structure

In addition to referring to the Instructions for Authors set out in the following, we also recommend using our templates to prepare the submission files.

Templates:

- Title page & back matter template Download

- Article template for Original Research Article Download

- Article template for Review Article and Perspective Article Download

2.3.1 Title Page & Back Matter

2.3.1.1 Title

The title of the manuscript should be concise, specific and relevant, with no more than 16 words and less than 120 characters (spaces included) if possible. When gene or protein names are included, the abbreviated name rather than full name should be used.

2.3.1.2 Authors and Affiliations

Authors' full names should be listed. Middle names can be presented as initials. Institutional addresses and email addresses for all authors should be listed while making submission via the submission platform. At least one author should be designated as corresponding author. In addition, corresponding authors are suggested to provide their Open Researcher and Contributor ID (ORCID) upon submission. Please note that any change to authorship is not allowed after manuscript acceptance, and under most circumstances, the author list and sequence is considered definitive at the time of submission.

While preparing the title page, insert an asterisk (*) next to the name of author serving as the corresponding author, and insert a dagger/obelisk symbol (^†) next to the names of the first few authors who should claim the joint first authorship.

Note that only the email addresses for the corresponding authors will be displayed on published articles.

2.3.1.3 Abstract

The abstract should provide the context or background for the study and should state the study's purpose, basic procedures (selection of study participants, settings, measurements, analytical methods), main findings (giving specific effect sizes and their statistical and clinical significance, if possible), and principal conclusions. It should emphasize new and important aspects of the study or observations, note important limitations, and not overinterpret findings. Clinical trial abstracts should include items that the CONSORT group has identified as essential. It is not allowed to contain results which are not presented and substantiated in the manuscript, or exaggerate the main conclusions. Citations should not be included in the abstract.

2.3.1.4 Keywords

Three to eight keywords should be provided, which are specific to the article and reasonably common within the subject discipline, yet reasonably common within the subject discipline.

2.3.1.5 Graphical Abstract

Graphical abstract is mandatory for original research article, review article and short communication, and is optional for perspective article. The purpose of presenting a graphical abstract is to give our readers all the essential inputs from a publication in an instant and bitesize manner.

Please provide a brief title of preferably no more than 8 words for the graphical abstract prepared.

Please follow the following guidelines in preparing graphical abstract tailored to different manuscript types:

(i) Original Research Article/Short Communication: The elements that should exist in the graphical abstract is similar to those present in the poster with which an academic or research would present their research findings in a conference. Crucial elements that should exist include title, background/introduction, methodology, key findings or result outputs, and conclusion.

(ii) Review Article/Perspective Article: Since a review or perspective does not present any new research findings, the graphical abstract for this manuscript type should focus on presenting the key ideas, concepts and perspectives derived from the work, all of which can be presented schematically.

Make sure that the texts in the diagram are legible at 100% zoom and in common font type. Please use hi-res figures/diagrams, and avoid using copyrighted materials.

Owing to its illustrative nature, authors should avoid verbosity in graphical abstract. Nevertheless, a diagram containing only pictures without proper or sufficient textual description is not qualified as a graphical abstract.

2.3.1.6 Acknowledgments

This is an optional section where authors can acknowledge people and/or institutions that provided non-financial support and/or helped with the research and/or preparation of the manuscript. People to be acknowledged include those who do not qualify as authors. Examples of non-financial support include externally-supplied equipment/biological sources, writing assistance, administrative support, and contributions from non-authors. Authors are responsible for obtaining the permission for acknowledging people and/or institutions to be included in this list. If none of the above are pertinent, state “None.”

2.3.1.7 Funding

Authors should declare all financial support and sources that were used to perform the research, analysis, and/or article publication. Financial support is generally in the form of grants, royalties, consulting fees and others. Organizations that provide the grants and grant numbers should be declared. If not applicable, state "None." in this section.

2.3.1.8 Conflict of Interest

At the time of submission, authors must declare any (potential) conflicts or competing interests with any institutes, organizations or agencies that might influence the integrity of results or objective interpretation of their submitted works. For more information, see our Conflict of Interest Policy. State “The authors declare they have no competing interests.” or words to that effect if the authors do not have anything to declare.

We also recognize that some authors may be bound by confidentiality agreements, in which cases authors need to state "The authors declare that they are bound by confidentiality agreements that prevent them from disclosing their competing interests in this work."

2.3.1.9 Authors' Contributions

Each author is expected to have made substantial contributions to the conception or design of the work, or the acquisition, analysis, or interpretation of data, or the creation of new software used in the work, or have drafted the work or substantively revised it. We encourage authors to use Contributor Roles Taxonomy (CRediT) in describing each contributor’s specific contribution to the scholarly output in the Author Contributions section.

Below shows a sample Author Contributions section written based on the CRediT:

Conceptualization: Ali Jackson, Helen Meyer
Formal analysis: Han Xiang
Investigation: All authors
Methodology: Dolores Hans, Tom Lewis-Hans, Han Xiang
Writing – original draft: Ali Jackson
Writing – review & editing: Helen Meyer, Joshua O’Brien

Mention “All authors” as the response if all of the listed authors contributed to the same role.

For single-authored article, please state "This is a single-authored paper. [Author name] is the sole author contributed to this work." (Replace the “[Author name]” with the actual author name.)

2.3.1.10 Ethics Approval and Consent to Participate

Research involving human subjects, human material or human data must be performed in accordance with the Declaration of Helsinki and approved by an appropriate ethics committee. An informed consent to participate in the study should also be obtained from participants, or their parents or legal guardians for children under 16. A statement detailing the name of the ethics committee (including the reference number where appropriate) and the informed consent obtained must appear in the manuscripts reporting such research.

For papers describing studies involving animals and primary cells obtained directly from humans/animals, a statement on ethical approval, as detailed above, must be included. More information is available at Editorial Policies.

Please describe the reasons that obtaining ethics approval is exempted, especially for research works involving humans and/or animals.

If none of these are applicable, please state "Not applicable."

2.3.1.11 Consent for Publication

If human subjects were involved, state what form of consent (e.g., written and/or verbal) and whether or not permission was obtained from each of the subjects to publish their data and/or images. Efforts must be made by the authors to at least mask or conceal any identifying information of the patients that appear in writing or within photographs. If consent taking was not performed when human subjects were involved, provide a justification herein.

If none of the above is pertinent, state "Not applicable."

2.3.1.12 Availability of Data

In order to maintain the integrity, transparency and reproducibility of research records, authors should include this section in their manuscripts, detailing how the readers can access the data supporting their findings. Data can be deposited into data repositories or published as supplementary information in the journal. Authors who cannot share their data openly should state that the data will not be shared and provide a justifiable reason.

Nevertheless, we encourage authors to reasonably share their raw data, for the sake of transparency, stating the following “Data is available from the corresponding author upon reasonable request.”

For manuscript that does not involve data analysis, please state "Not applicable."

2.3.1.13 Further Disclosure

This section is reserved to inform the readers and editors of a few aspects:

(i) Part of or the entire set of findings and/or ideas in the submitted manuscript have been presented in a conference, academic meeting, congress, and so on. In this case, state the name, date and location of the event, and to what extent the findings and/or ideas in the manuscript have been presented. If these presented contents have been released by the event organizer or committee, please indicate the source of the material for transparency reasons.

(ii) The paper has been uploaded to or deposited in a preprint server. In this case, provide the name of the preprint server and associated accession number or DOI of the preprint.

(iii) The paper has been polished and edited with the aid of AI-powered tools, regardless of types and platforms. In this case, state the name of the tools and to what extent the paper was edited using these tools. See section 1.5 (The use of AI in manuscript preparation) for our editorial policy on AI usage.

2.3.2 Main Text

Manuscripts of different types are structured with different sections of content. Please refer to section 2.2 (Types of Manuscripts) for more details.

We strongly advise authors to adopt a concise manner in reporting scientific and academic works, while upholding utmost clarity.

2.3.2.1 Introduction

The introduction should contain background that puts the manuscript into context, allow readers to understand why the study is important, include a brief review of key literature, and conclude with a brief statement of the overall aim of the work and a comment about whether that aim was achieved. Relevant controversies or disagreements in the field should be introduced as well.

2.3.2.2 Methods

Methods should contain sufficient details to allow others to fully replicate the study. New methods and protocols should be described in detail while well-established methods can be briefly described or appropriately cited. The materials used (including drugs, chemicals, reagents, commercial kits, etc.), the cell line used, the statistical methods taken, and the computer software used should be identified precisely. The origin of the materials, instruments and software used in a research work should be disclosed, including the name of manufacturer/developer and country/region. Statistical terms, abbreviations, and all symbols used should be defined clearly. Protocol documents for clinical trials, observational studies, and other non-laboratory investigations may be treated as supplementary materials, presented in the Supplementary File.

The methodology should be reported in a way that is sufficient for others to repeat the experiments and generate the same results.

2.3.2.3 Results

This section contains the findings of the study. Results of statistical analysis should also be included either as text or as figures (see section 2.4.4) or tables (see section 2.4.5) if appropriate. Authors should emphasize and summarize only the most important observations. Data on all primary and secondary outcomes identified in the section Methods should also be provided. Extra or supplementary information and technical details can be presented in the Supplementary File.

Authors are strongly advised not to reiterate data already shown or summarized in the figures and/or tables. This section serves to present a summary of all the visual results presented in the paper, along with result statements that can only be made in a textual manner, giving an unbiased and honest direction in how the data are or should be interpreted.

2.3.2.4 Discussion

This section should discuss the implications of the findings in context of existing research and highlight limitations of the study. Future research directions may also be mentioned.

2.3.2.5 Conclusion

It should state clearly the main conclusions and include the explanation of their relevance or importance to the field.

2.3.2.6 References

Authors are responsible for the accuracy and completeness of their references and for correct text citations. Number references should be in the order they appear in the text; do not alphabetize them. In text, tables, and legends, identify references with superscript Arabic numerals. When listing references, follow AMA style and abbreviate the names of journals according to the journals list in PubMed. List all authors and/or editors up to 6; if more than 6, list the first 3 followed by "et al." Note: Journal references should include the issue number in parentheses after the volume number.

Examples of reference style:

1. Youngster I, Russell GH, Pindar C, Ziv-Baran T, Sauk J, Hohmann EL. Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficileinfection. JAMA. 2014;312(17):1772-1778.
2. Murray CJL. Maximizing antiretroviral therapy in developing countries: the dual challenge of efficiency and quality [published online December 1, 2014]. JAMA. doi:10.1001/jama.2014.16376.
3. Centers for Medicare & Medicaid Services. CMS proposals to implement certain disclosure provisions of the Affordable Care Act. http://www.cms.gov/apps/media/press/factsheet.asp?Counter=4221. Accessed January 30, 2012.
4. McPhee SJ, Winker MA, Rabow MW, Pantilat SZ, Markowitz AJ, eds. Care at the Close of Life: Evidence and Experience. New York, NY: McGraw Hill Medical; 2011

For more examples of electronic references, click here.

The journal also recommends that authors prepare references with a bibliography software package, such as EndNote to avoid typing mistakes and duplicated references.

Note that a lack of compliance to these referencing style and guidelines will result in delayed production and publication.

2.3.2.7 Supplementary materials

Additional data and information can be submitted as supplementary materials, accompanying the main manuscript. The supplementary materials will also be available to the reviewers during the peer-review process.

Briefly, the supplementary materials can be categorized into several types:

(1) Supplementary File. Supplementary File should be submitted in MS Word file, containing figures and/or tables that are not regarded as major results from the work presented. All figures, tables, videos and audioclips presented and mentioned in the Supplementary File should be labeled with a prefix ‘S’, for instance: Figure S1, Table S1, Video S1, and Audio S1. All of these labels should be presented in numerical order, according to their material type. Both supplementary figures and tables should be included in the Supplementary File, together with their respective captions and descriptions. Please apply the same standards in preparing supplementary figures and tables. While supplementary videos and audioclips cannot be presented (or played) directly in or through the Supplementary File, it is important for authors to incorporate the captions and description of these materials in the Supplementary File in a systematic manner. Algorithms can also be presented in the Supplementary File. If possible, all of these materials should also be mentioned in the main manuscript in chronological manner to help readers gain a sense of their relevance to the main findings or concepts.

(2) Supplementary videos and audio clips. Supplementary videos and audioclips should be labeled with a prefix ‘S’, for instance: Video S1 and Audio S1. The allowable formats for these materials are: mp3, wav or wma for audio; and avi, divx, flv, mov, mp4, mpeg, mpg or wmv for video. Videos and audios should be presented in English with an easy-to-understand tone. The frames should be clear, and the speed of narration should be moderate. Each of these materials is limited to a size of 500 MB. If the file size requirement cannot be fulfilled, please consider uploading the materials on public repository for research purposes and disclose the link (preferable the DOI) in the corresponding captions stated in Supplementary File. It is the author’s responsibility in ensuring the quality of the multimedia materials provided and the editors/publisher has the right to request enhancements if the original materials do not meet our desired standards.

(3) Data sheets. Data sheets are big chunks of high-dimensional data that cannot be ‘compressed’ into tables presentable in a MS Word document. Typically, data sheets can be presented in word, excel, csv, cdx, fasta, or pdf files. Authors should be responsible for ensuring the clarity and presentability of raw data in the data sheets shared.

2.4 Manuscript Formats

2.4.1 File Formats

Manuscript files can be in DOC and DOCX formats and should not be locked or protected.

2.4.2 Length

The word limit is specified in the item "Types of Manuscripts". Authors are encouraged to present and discuss their findings concisely.

2.4.3 Language

Manuscripts must be written in English.

2.4.4 Figures

Figures should be cited in numerical order (e.g., Figure 1, Figure 2) and placed right after the point where it is directly related or after the paragraph where they are first cited.
Figures can be submitted in formats of tiff, jpeg and png, with a resolution of 300-600 dpi.Please use hi-res figures/diagrams.
Use sentence casing throughout, except for abbreviations/acronyms and proper nouns.
Make sure that the texts in the diagram are legible at 100% zoom and in common font type.
Figure caption is placed under the Figure.
Figure and its caption and legend should be inserted right after the paragraph where it is mentioned for the first time.In-text citations that are contained within the figures and/or their captions/legends should be arranged in the same numerical and chronological flow like others in the main text.
Diagrams with describing words (includingflow charts, coordinate diagrams, bar charts, line charts and scatter diagrams, etc.) should be editable in word, excel or powerpoint format. Non-English information should be avoided.
Labels, numbers, letters, arrows, and symbols in figure should be clear, of uniform size, and contrast with the background.
Symbols, arrows, numbers, or letters used to identify parts of illustrations must be identified and explained in the legend.
Internal scale (magnification) should be explained and the staining method in photomicrographs should be identified.
All non-standard abbreviations should be defined in full term in the legend,in alphabetical order, for instance: ABC: American-born Chinese; PCR: Polymerase chain reaction.
Permission for use of copyrighted materials from other sources, including re-published, adapted, modified, or partial figures and images from the internet, must be obtained. It is authors' responsibility to acquire the permissions from the copyright holders or the authorized personnel, to follow any citation instructions requested by third-party rights holders, and to cover any supplementary chargesincurred.
Online and open-source softwareand platforms used to create diagrams presented in the manuscript should be appropriately acknowledged.

2.4.5 Tables

Tables should be cited in numerical order and placed right after the point where it is directly related or after the paragraph where they are first cited.
The table caption should be placed above the table and labeled sequentially (e.g., Table 1, Table 2).
Table and its caption and legend should be inserted right after the paragraph where it is mentioned for the first time. In-text citations that are contained within the table should be arranged in the same numerical and chronological flow like others in the main text.
Tables should be provided in editable form like the DOC or DOCX format.
Use sentence casing throughout, except for abbreviations/acronyms and proper nouns.
All non-standard abbreviations should be defined in full term in the legend, in alphabetical order, for instance: ABC: American-born Chinese; PCR: Polymerase chain reaction.
Authors must take responsibility in the efficient presentation of tables generated.
Explanatory matter should also be placed in footnotes.
Permission for use of copyrighted materials from other sources, including re-published, adapted, modified, or partial tables from the internet, must be obtained. It is authors' responsibility to acquire the permissions from the copyright holders or the authorized personnel, to follow any citation instructions requested by third-party rights holders, and to cover any supplementary charges incurred.

2.4.6 Abbreviations

Abbreviations should be defined upon first appearance in the abstract, main text, and in figure or table captions and used consistently thereafter. Non-standard abbreviations are not allowed unless they appear at least three times in the text. Commonly used abbreviations, such as DNA, RNA, ATP, etc., can be used directly without definition. Abbreviations in titles and keywords should be avoided, except for the ones which are widely used.

2.4.7 Italics

The use of italics for emphasis is up to the authors. Make sure there are no misunderstandings. Words like vs., et al., etc., in vivo, in vitro; t test, F test, U test; related coefficient such as r, sample number such as n, and probability such as P; gene symbols; names of bacteria and biology species in Latin should be kept in Italic form.

Regarding gene symbols, please use the standard gene symbols throughout the paper.

2.4.8 Units

SI Units should be used. Imperial, US customary and other units should be converted to SI units whenever possible. There is a space between the number and the unit (i.e., 23 mL). Hour, minute, second should be written as h, min, s.

2.4.9 Numbers

Numbers appearing at the beginning of sentences should be expressed in English. When there are two or more numbers in a paragraph, they should be expressed as Arabic numerals; when there is only one number in a paragraph, number < 10 should be spelled out in English and number > 10 should be expressed as Arabic numerals. 12345678 should be written as 12,345,678.

2.4.11 Equations

Equations should be editable and not appear in a picture format. Authors are advised to use either the Microsoft Equation Editor or the MathType for display and inline equations.

2.5 Submission Link

Submit your article here.

3. Research and Publication Ethics

Please refer to ASP Research and Publication Ethics.

4. Authorship

Authorship credit should be solely based on substantial contributions to a published study, as specified in the following four criteria:

Substantial contributions to the conception or design of the work, or the acquisition, analysis, or interpretation of data for the work;
Drafting the work or revising it critically for important intellectual content;
Final approval of the version to be published;
Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

All those who meet those criteria should be identified as authors. Authors must specify their contributions in the Author Contributions section of their manuscripts. Contributors who do not meet all the four criteria (like only involved in acquisition of funding, general supervision of a research group, general administrative support, writing assistance, technical editing, language editing, proofreading, etc.) should be acknowledged in the section of Acknowledgement in the manuscript rather than being listed as authors.

If a large multiple-author group has conducted the work, the group ideally should decide who will be authors before the work starts and confirm authors before submission. All authors of the group named as authors must meet all the four criteria for authorship.
AI and AI-assisted technologies should not be listed as an author or co-author.

5. Suggesting / Excluding Reviewers

During the submission process, please suggest three potential reviewers with the appropriate expertise to review the manuscript. The editors will not necessarily approach these referees. Please provide detailed contact information (addresses, homepages, phone numbers, and e-mail addresses). The proposed referees should neither be current collaborators of the co-authors nor have published with any of the co-authors of the manuscript within the last three years. Proposed reviewers should be from different institutions from those of the authors. You may identify appropriate Editorial Board members of the journal as potential reviewers and suggest reviewers from the authors that you frequently cite in your papers.

You are welcome to exclude a limited number of researchers as potential Editors or reviewers of your manuscript. To ensure a fair and rigorous peer review process, we ask that you keep your exclusions to a maximum of three people. If you wish to exclude additional referees, please explain or justify your concerns—this information will be helpful for Editors when they decide whether to honor your request.

6. Editors and Journal Staff as Authors

Editorial independence is extremely important and Editorial Office staff does not interfere with editorial decisions.

Editorial staff or Editors shall not be involved in the processing of their own academic work. Submissions authored by editorial staff/Editors will be assigned to at least two independent external reviewers. Decisions will be made by other Editorial Board members who do not have conflict of interests with the author. Journal staff are not involved in the processing of their own work submitted to any journals published by AccScience Publishing.

7. Policy of Use of AI and AI-assisted Technologies in Scientific Writing

Generative AI and AI-assisted technologies (e.g., large language models) are expected to be increasingly used to create content. In the writing process of manuscripts, using AI and AI-assisted technologies to complete key researcher work, such as producing scientific insights, analyzing and interpreting data or drawing scientific conclusions, is not allowed, and they should only be used to improve the readability and language of manuscripts.

AI and AI-assisted technologies should be used under human control and supervision as they may generate incorrect or prejudiced output, and they should not be listed as an author or co-author, nor cited as an author.

The use of AI and AI-assisted technologies should be disclosed by authors in their manuscripts, and a statement will be required in the final publication.

AccScience Publishing will keep monitoring the development and adjust the policy when necessary.

8. Conflict of Interests

Authors are required to declare any possible financial and/or non-financial conflicts of interest in the cover letter and back matter, as well as confirm this when submitting their manuscript in the submission system. If no conflicts of interest exist, authors need to state "The authors declare no conflicts of interest." We also recognize that some authors may be bound by confidentiality agreements, in which cases authors need to state "The authors declare that they are bound by confidentiality agreements that prevent them from disclosing their competing interests in this work."

9. Editorial Process

Please refer to the Editorial Process.

10. Contact Us

Ms. Zoe Zhang
Managing Editor
an.office@accscience.sg

Locations

Advanced Neurology
Singapore Headquarters
8 Burn Road#15-03 Trivex Singapore 369977
Office Hours: 9:00-17:00 (GMT +8)

Beijing Office, China
Tel: +010-6030 6742
Area 1, Hanwei International Plaza, 186 Neihuan West Road, Fengtai District, Beijing, China
Office Hours: 9:00-17:30 (GMT +8)

Kuala Lumpur Office, Malaysia
Tel: +603 9549 5873
30-2, Jalan BS 1/2, Olive Hill Business park, 43300 Seri Kembangan, Selangor, Malaysia
Office Hours: 8:30-17:30 (GMT +8)

Last updated on February 14, 2025

Advanced Neurology, Electronic ISSN: 2810-9619 Print ISSN: 3060-8589, Published by AccScience Publishing